News

September 11, 2025

NOF to Exhibit and Present at Discovery & Development US 2025

Tokyo, Japan — NOF CORPORATION is pleased to announce its participation in the upcoming Discovery and Development US 2025, which will be held at the Sheraton San Diego Resort, San Diego, CA, USA on October 2 and 3.

The company is a Gold Sponsor of the event.

As a part of the event, NOF CORPORATION will showcase its products for the Drug Delivery System at Booth #67.

Furthermore, Syed Reza (Scientific and Sales Consultant), and Taiki Morita (Senior Scientist at Life Science Division) will each deliver presentation on October 2, with further details outlined below.

Presentation 1
(Formulation & Delivery Program)

Title
Development of an Influenza LNP-mRNA Vaccine with Tailored Immunogenicity

Date & Time
October 2 / 11:50 a.m. – 12:10 p.m. (PDT)

Speaker
Syed Reza, Scientific and Sales Consultant, NOF AMERICA CORPORATION

Abstract
We will present advances in creating ionizable lipids with tunable immunogenic profiles and their use in creating vaccines favoring cellular or humoral responses. Finally, a case study of a mRNA vaccine against influenza shall be discussed.

Presentation 2
(ADC Delivery & Development Program)

Title
Development and Evaluation of Novel Cleavable Pendant Type PEG Linkers For ADCs

Date & Time
October 2 / 1:35 p.m. – 1:55 p.m. (PDT)

Speaker
Taiki Morita, Senior Scientist at Life Science Division, NOF CORPORATION

Abstract
We developed cleavable pendant-type PEG linkers enabling DAR8-ADCs with reduced hydrophobicity. PEG8/PEG12 linkers showed superior PK and efficacy over DAR4-ADCs. Notably, DAR8-ADC with PEG12 showed high tolerability with no weight loss in vivo.

Should you have any questions or inquiries about the topic, we kindly ask you to submit them through the Contact page.


See Also:


[View in PDF]